Pyxis Oncology Successfully Completes Acquisition of Apexigen
Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as…
Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as…
Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as…
FREMONT, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
FREMONT, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
Patent provides protection through late 2039 for drug candidates with potential to improve cardiac function…
Patent provides protection through late 2039 for drug candidates with potential to improve cardiac function…
WARREN, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
WARREN, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
Planegg/Martinsried, August 23, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…
Planegg/Martinsried, August 23, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…
ROCKAWAY, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
ROCKAWAY, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
MALVERN, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
MALVERN, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
Patient Wound Scores with Associated Bacterial Cultures Patient Wound Scores with Associated Bacterial Cultures Patients…
Patient Wound Scores with Associated Bacterial Cultures Patient Wound Scores with Associated Bacterial Cultures Patients…
Designed to demonstrate delivery of TTX-MC138 to metastatic lesions BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE)…
Designed to demonstrate delivery of TTX-MC138 to metastatic lesions BOSTON, Aug. 23, 2023 (GLOBE NEWSWIRE)…
Verrica’s product YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious…
Verrica’s product YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious…